TriSalus Life Sciences (TLSI) Misses Q3 EPS by 96c

TriSalus Life Sciences (NASDAQ: TLSI) reported Q3 EPS of ($0.96). Revenue for the quarter came in at $11.6 million.

For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• BofA launches AI tracker as Claude leads intelligence rankings
• BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform